Bill Text: MI SR0147 | 2021-2022 | 101st Legislature | Enrolled
Bill Title: A resolution to designate May 2022 as Brain Tumor Awareness Month.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2022-05-25 - Adopted [SR0147 Detail]
Download: Michigan-2021-SR0147-Enrolled.html
MICHIGAN SENATE
Senate Resolution No. 147
Offered by Senator Hollier
A RESOLUTION TO DESIGNATE MAY 2022
AS BRAIN TUMOR AWARENESS MONTH
WHEREAS, Brain tumors, specifically glioblastoma, have become recognized in recent years as one of the deadliest cancers; and
WHEREAS, May has long been recognized across America as Brain Tumor Awareness Month in an effort to raise public awareness about the importance of symptoms and advanced treatment options. Brain tumors continue to be one of the most difficult cancers to detect in the early stages of the disease, which contributes to its high mortality rates; and
WHEREAS, There are an estimated 770 new diagnoses of brain tumors in Michigan in 2022, and an estimated 600 Michigan residents will die from a brain tumor this year; and
WHEREAS, Brain tumors can be deadly and can severely impact the quality of life of those fortunate enough to survive it. Brain tumors continue to be the leading cause of cancer deaths among children and young adults; and
WHEREAS, Brain tumors have the highest per-patient initial cost of care for any cancer group with an annualized cost, as of 2018, at nearly $150,000; and
WHEREAS, More than any other cancer, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life; and
WHEREAS, Michigan received national recognition as a leading center of excellence for brain tumor treatment and research due to the number of patients traveling to the state for clinical trial participation, the local grant dollars used to create jobs in the field, and the highly trained professionals specializing in brain tumors across the state; and
WHEREAS, Michigan is proud to be the home of high level brain cancer centers such as the Hermelin Brain Tumor Center at Henry Ford Hospital and the Rogel Cancer Center at the University of Michigan; and
WHEREAS, Despite the number of brain tumors diagnosed annually, and their devastating prognosis, there have only been four United States Food and Drug Administration (FDA) approved drugs and one device to treat brain tumors in the past thirty years; and
WHEREAS, To date, there are not any drugs that have been developed and approved specifically for malignant pediatric brain tumors. The four FDA-approved drugs for brain tumors only provide incremental improvements to patient survival, and unfortunately, mortality rates remain relatively unchanged; and
WHEREAS, We take this time to encourage Michigan residents to be vigilant and proactive when it comes to their brain health; now, therefore, be it
RESOLVED BY THE SENATE, That the members of this legislative body designate May 2022 as Brain Tumor Awareness Month. We encourage efforts to increase awareness and education about brain tumors among the general public; and be it further
RESOLVED, That we recognize the need for additional research into diagnosis, screening, and treatments for brain tumors. We urge all Michiganders to use this month as an opportunity to educate themselves about brain tumors and cancer.
Adopted by the Senate, May 25, 2022.
Secretary of the Senate
